McFarlane Neil F.
Zevra Therapeutics, Inc. · President and CEO
McFarlane Neil F. is listed in filings as President and CEO at Zevra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 10, 2026, including sale activity. Recent filings connect the profile to Zevra Therapeutics, Inc. (ZVRA). The current snapshot covers public activity from Feb 3, 2025 to Feb 10, 2026. Reported amounts are shown as $125.2K to $2.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $853k91k shares | SellFeb 2, 2026 | $9.38 | $12.82 | |
| $211k19.5k shares | SellOct 10, 2025 | $10.82 | $12.82 | |
| $246k30.5k shares | SellFeb 14, 2025 | $8.05 | $12.82 | |
| $481k61.3k shares | SellFeb 13, 2025 | $7.86 | $12.82 |